Our top pick for
Isoray Inc is a medical instruments & supplies business based in the US. Isoray shares (ISR) are listed on the NYSE MKT and all prices are listed in US Dollars. Isoray employs 61 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.63|
|52-week range||$0.35 - $2.81|
|50-day moving average||$0.64|
|200-day moving average||$0.75|
|Wall St. target price||$1.97|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.03|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-19)||1.61%|
|1 month (2021-09-24)||-4.47%|
|3 months (2021-07-26)||-10.29%|
|6 months (2021-04-26)||-33.68%|
|1 year (2020-10-26)||65.62%|
|2 years (2019-10-25)||105.35%|
|3 years (2018-10-26)||35.51%|
|5 years (2016-10-26)||0.6404|
|Revenue TTM||$10.1 million|
|Gross profit TTM||$5.1 million|
|Return on assets TTM||-5.43%|
|Return on equity TTM||-9.26%|
|Market capitalisation||$90.8 million|
TTM: trailing 12 months
There are currently 1.7 million Isoray shares held short by investors – that's known as Isoray's "short interest". This figure is 64.4% up from 1.0 million last month.
There are a few different ways that this level of interest in shorting Isoray shares can be evaluated.
Isoray's "short interest ratio" (SIR) is the quantity of Isoray shares currently shorted divided by the average quantity of Isoray shares traded daily (recently around 781961.86046512). Isoray's SIR currently stands at 2.15. In other words for every 100,000 Isoray shares traded daily on the market, roughly 2150 shares are currently held short.
However Isoray's short interest can also be evaluated against the total number of Isoray shares, or, against the total number of tradable Isoray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Isoray's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Isoray shares in existence, roughly 10 shares are currently held short) or 0.012% of the tradable shares (for every 100,000 tradable Isoray shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Isoray.
Find out more about how you can short Isoray stock.
We're not expecting Isoray to pay a dividend over the next 12 months.
Isoray's shares were split on a 1:30 basis on 16 August 2005. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Isoray shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Isoray shares which in turn could have impacted Isoray's share price.
Over the last 12 months, Isoray's shares have ranged in value from as little as $0.352 up to $2.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Isoray's is 1.0286. This would suggest that Isoray's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Isoray, Inc. , through its subsidiary, IsoRay Medical, Inc. , develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.